Doctor Group Warns Of Kala Azar Spread In India, Southeast Asia
This article was originally published in PharmAsia News
Executive Summary
An official of Medecins Sans Frontieres warned Southeast Asian governments they need to make drugs more accessible to the poor as visceral leishmaniasis spreads and becomes treatment-resistant. The international group's tropical medical adviser said the disease, transmitted by sand flies, has an effective treatment in Ambisome (liposomal amphotericin B), shown to be 98 percent effective so far. But, she said, it and other drugs to fight the disease are not available to the people who need them most. At a conference in India where the potentially fatal disease is endemic, she called for it to be included in India's treatment protocol as a first-line option. (Click here for more
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.